Life ScienceCompany
Chiesi Farmaceutici has acquired 5 companies. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.
Chiesi Farmaceutici’s largest acquisition to date was in 2017, when it acquired Raptor Pharmaceuticals for $70M. Chiesi Farmaceutici has acquired in 2 different US states, and 4 countries. The Company’s most targeted sectors include life science (60%) and healthcare services (20%).
Join Mergr and gain access to Chiesi Farmaceutici’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity5
- M&A Buy Activity5
- M&A Sell Activity1
- Total Sectors Invested 2
- Total Countries Invested 4
- M&A Buy/Sell Connections 3
- M&A Advisors 2
Unlimited Searches
